IBIO : Summary for iBio, Inc. Common Stock - Yahoo Finance

U.S. Markets open in 7 hrs 3 mins

iBio, Inc. (IBIO)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.44+0.02 (+4.74%)
At close: 4:45PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.42
Bid0.00 x
Ask0.00 x
Day's Range0.42 - 0.46
52 Week Range0.33 - 0.80
Avg. Volume129,775
Market Cap39.2M
PE Ratio (TTM)-3.19
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube10 hours ago

    ETFs with exposure to iBio, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to iBio, Inc. Here are 5 ETFs with the largest exposure to IBIO-US. Comparing the performance and risk of iBio, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017
    Capital Cube8 days ago

    iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis iBio, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of iBio, Inc. – Genocea Biosciences, Inc., Johnson & Johnson, Aviragen Therapeutics Inc, Newlink Genetics Corporation, PharmAthene, Inc., Nektar Therapeutics, Achaogen, Inc., Emergent BioSolutions Inc. and Immunomedics, Inc. (GNCA-US, JNJ-US, ... Read more (Read more...)

  • Marketwired2 months ago

    Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

    iBio, Inc. On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval of a settlement of the derivative action captioned Spencer Savage ...